Cabot Corporation
CBT · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $4,139 | $4,013 | $4,490 | $4,958 |
| - Cash | $239 | $239 | $213 | $183 |
| + Debt | $1,215 | $1,215 | $1,289 | $1,198 |
| Enterprise Value | $5,115 | $4,989 | $5,566 | $5,973 |
| Revenue | $899 | $923 | $936 | $955 |
| % Growth | -2.6% | -1.4% | -2% | – |
| Gross Profit | $220 | $244 | $241 | $235 |
| % Margin | 24.5% | 26.4% | 25.7% | 24.6% |
| EBITDA | $175 | $213 | $208 | $199 |
| % Margin | 19.5% | 23.1% | 22.2% | 20.8% |
| Net Income | $43 | $101 | $94 | $93 |
| % Margin | 4.8% | 10.9% | 10% | 9.7% |
| EPS Diluted | 0.8 | 1.86 | 1.69 | 1.67 |
| % Growth | -57% | 10.1% | 1.2% | – |
| Operating Cash Flow | $219 | $249 | $73 | $124 |
| Capital Expenditures | -$64 | -$34 | -$99 | -$77 |
| Free Cash Flow | $155 | $215 | -$26 | $47 |